Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis

Journal of Medical Virology

Volumn 60, Issue 1, 2000, Pages 21-27

  Negro, Francesco ^a   Samii, Kaveh ^a   Rubbia Brandt, Laura ^a   Quadri, Rafael ^c   Male, Pierre Jean ^c   Zarski, Jean Pierre ^b   Baud, Marilyn ^b   Giostra, Emile ^c   Beris, Photis ^a   Hadengue, Antoine ^c  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

Alfa interferon; Chronic viral hepatitis; HFE gene; Iron overload; Viral pathogenesis

Indexed keywords

IRON; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER FIBROSIS; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDEROSIS;

ADULT; AGED; FEMALE; HEMOCHROMATOSIS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; IRON; IRON OVERLOAD; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION; RNA, VIRAL; SIDEROSIS;

EID: 0033991918     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200001)60:1<21::AID-JMV4>3.0.CO;2-F     Document Type: Article

References (49)

1. Arber N, Moshkowitz M, Konikoff F, Halpern Z, Hallak A, Santo M, Tiomny E, Baratz M, Gilat T. 1995. Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection. Dig Dis Sci 40:2431-2433.
2. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB. 1995. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 95:2067-2075.
3. Banner BF, Barton AL, Cable EE, Smith L, Bonkowsky HL. 1995. A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C. Mod Pathol 8:232-238.
4. Baynes RD, Cook JD, Keith J. 1995. Interleukin-11 enhances gastro-intestinal absorption of iron in rats. Br J Haematol 91:230-233.
5. Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA, Kirsch RE. 1996. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 25:633-638.
6. Beris P, Samii K, Darbellay R, Zoumbos N, Tsoplou P, Kourakli A, Proud'Homme C, Fenaux P. 1999. Iron overload in patients with sideroblastic anemia is not related to the presence of hemochromatosis Cys282Tyr and His63Asp mutations. Br J Haematol 104: 97-99.
7. Bonkowsky HL, Banner BF, Rothman AL. 1997. Iron and chronic viral hepatitis. Hepatology 25:759-768.
8. Bonkowsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio MG, Lambrecht RW. 1998. Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 27:1661-1669.
9. Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y. 1997. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 41:115-120.
10. Bronowicky JP, Loriot MA, Thiers V, Grignon Y, Zignego AL, Brechot C. 1998. Hepatitis C virus persistence in human hematopoietic cells injected into scid mice. Hepatology 28:211-218.
11. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. 1982. Hepatic iron stores and markers of iron overload in alcoholics and patients with hemochromatosis. Dig Dis Sci 27:909-916.
12. Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dessì C, Melis A, Mazzoleni AP, Cornacchia G, Cao A, De Virgiliis S. 1994. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 125:123-128.
13. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, Seed CRG, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Olim G, Duraisamy G, Cuypers T, Saeed AA, Teo D, Conradie J, Kew MC, Lin M, Nuchaprayoon C, Ndimbie OK, Yap PL. 1995. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 76:1197-1204.
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. 1994. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19:1513-1520.
15. Deugnier YM, Turlin B, Powell LW, Summers KM, Moirand R, Fletcher L, Loréal O, Brissot P, Halliday JW. 1993. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 17:30-34.
16. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. 1992. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108-2113.
17. Di Marco V, Lo Iacono O, Almasio P, Ciaccio C, Capra M, Rizzo M, Malizia R, Maggio A, Fabiano C, Barbaria F, Craxì A. 1997. Long-term efficacy of α-interferon in β-thalassemics with chronic hepatitis C. Blood 90:2207-2212.
18. Dinarello CA. 1988. Biology of interleukin-1. FASEB 2:108.
19. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R. 1995. Iron storage, lipid peroxydation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22:449-456.
20. Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, Cecchetto A, Grigioni W. 1996. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology 23:1468-1475.
21. Feder JN, Gnirke A, Thoma W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo RJr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. 1996. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Gen 13:399-408.
22. Fong TL, Han SH, Tsai NCS, Morgan TR, Mizokami M, Qian D, Phan C, Goad K, Redeker AG. 1998. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C. J Hepatol 28:369-374.
23. Haque S, Chandra B, Gerber MA, Lok ASF. 1996. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 27:1277-1281.
24. Hezode C, Cazeneuve C, Coué O, Pawlotsky JM, Zafrani ES, Amselem S, Dhumeaux D. 1998. Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C. Hepatology 27:306.
25. Hezode C, Cazeneuve C, Coué O, Roudot-Thoraval F, Pawlotsky JM, Zafrani ES, Amselem S, Dhumeaux D. 1999. Hemochromatosis Cys282Tyr mutation and histological fibrosis in patients with C virus chronic hepatitis. Hepatology 29:1338.
26. Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Noguchi O, Miyake S, Nouchi T, Fujisawa K, Marumo F, Sato C. 1996. Hepatic iron contents and response to interferon-α in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus. Dig Dis Sci 41:989-994.
27. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K, Nonomura A. 1995. Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C. Hum Pathol 26:1080-1085.
28. Kaji K, Nakanuma Y, Harada K, Sakai A, Kaneko S, Kobayashi K. 1997. Hemosiderin deposition in portal endothelial cells is a histologic marker predicting poor response to interferon-α therapy in chronic hepatitis C. Pathol International 47:347-352.
29. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl PE, Penner E, Ferenci P. 1999. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116:127-134.
30. Lérat H, Rumin S, Habersetzer F, Berby F, Trabaud MA, Trépo C, Inchauspé G. 1998. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91:3841-3849.
31. LeSage GD, Baldus WP, Fairbanks VF, Baggenstoss AH, McCall B, Breanndan Moore S, Taswell HF, Gordon H. 1983. Hemochromatosis: genetic or alcohol-induced? Gastroenterology 84:1471-1477.
32. Mandishona E, MacPhail AP, Gordeuk VR, Kedda MA, Paterson AC, Rouault TA, Kew MC. 1998. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 27: 1563-1566.
33. Mathur A, Bharadwaj M, Chatuverdi UC. 1990. Alteration in iron levels in Japanese encephalitis virus infection. J Exp Pathol 71: 307.
34. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. 1985. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82:6133-6137.
35. Negro F, Giostra E, Krawczynski K, Quadri R, Rubbia-Brandt L, Mentha G, Colucci G, Perrin L, Hadengue A. 1998. Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR. Preliminary application to the liver transplantation model. Journal of Hepatology 29:1-11.
36. Negro F, Krawczynski K, Quadri R, Rubbia-Brandt L, Mondelli M, Zarski JP, Hadengue A. 1999. Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semi-quantitative RT-PCR. Hepatology 29:536-542.
37. Olynyk JK, Reddy R, Di Bisceglie AM, Jefiers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR. 1995. Hepatic iron concentration as a predictor of response to Interferon alfa therapy in chronic hepatitis C. Gastroenterology 108:1104-1109.
38. Piperno A, D'Alba R, Fargion S, Roffi L, Sampietro M, Parma S, Arosio V, Fare M, Fiorelli G. 1995. Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 7:1203-1208.
39. Piperno A, Vergani A, Malosio I, Parma L, Fossati L, Ricci A, Bovo G, Boari G, Mancia G. 1998. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology 28:1105-1109.
40. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. 1997. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321-323.
41. Sacco R, Randone A, Flichman D, Oliveri F, Colombatto P, Scaraggi FA, Bonino F, Schiraldi O, Brunetto MR. 1997. The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. Clin Diagn Virol 8:189-194.
42. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, Malosio I, Mattioli M, Fracanzani AL, Cappellini MD, Fiorelli G, Fargion S. 1998. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 27: 181-184.
43. Shaheen NJ, Bacon BR, Grimm IS. 1998. Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation. Hepatology 28:526-529.
44. Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. 1998. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27:1695-1699.
45. Tsukamoto H, Home W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S, Brittenham GM. 1995. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-630.
46. Turlin B, Deugnier Y. 1997. Histological assessment of liver siderosis J Clin Pathol 50:971.
47. Uchida T. 1995. Overview of iron metabolism. Int J Hematol 62:193-202.
48. Van Thiel DH, Friedlander L, Molloy PJ, Kania RJ, Fagiuoli S, Wright HI, Gasbarrini A, Caraceni P. 1996. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy. Hepatogastroenterology 43:1557-1561.
49. Yaouanq J, Grosbois B, Jouanolle AM, Goasguen J, Leblay R. 1997. Haemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anaemia. Lancet 349:1475-1476.